Cargando…
Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast‐rich mimics
Driver mutations in the two histone 3.3 (H3.3) genes, H3F3A and H3F3B, were recently identified by whole genome sequencing in 95% of chondroblastoma (CB) and by targeted gene sequencing in 92% of giant cell tumour of bone (GCT). Given the high prevalence of these driver mutations, it may be possible...
Autores principales: | Presneau, Nadège, Baumhoer, Daniel, Behjati, Sam, Pillay, Nischalan, Tarpey, Patrick, Campbell, Peter J, Jundt, Gernot, Hamoudi, Rifat, Wedge, David C, Loo, Peter Van, Hassan, A Bassim, Khatri, Bhavisha, Ye, Hongtao, Tirabosco, Roberto, Amary, M Fernanda, Flanagan, Adrienne M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858131/ https://www.ncbi.nlm.nih.gov/pubmed/27499898 http://dx.doi.org/10.1002/cjp2.13 |
Ejemplares similares
-
Fibroblastic growth factor receptor 1 amplification in osteosarcoma is associated with poor response to neo-adjuvant chemotherapy
por: Fernanda Amary, M, et al.
Publicado: (2014) -
H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone
por: Amary, Fernanda, et al.
Publicado: (2017) -
Recurrent rearrangements of FOS and FOSB define osteoblastoma
por: Fittall, Matthew W., et al.
Publicado: (2018) -
Synovial chondromatosis and soft tissue chondroma: extra-osseous cartilaginous tumours defined by FN1 gene rearrangement
por: Amary, Fernanda, et al.
Publicado: (2019) -
Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2
por: Guilhamon, Paul, et al.
Publicado: (2013)